Dror Harats | Chief Executive Officer |
Sam Backenroth | Chief Financial Officer |
Kevin DeGeeter | Oppenheimer |
Swayampakula Ramakanth | H.C. Wainwright |
Jonathan Aschoff | ROTH Capital Partners |
Jonathan Kreizman | Valore Research |
Good morning and welcome to VBL Therapeutics Third Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode and please note that this conference is being recorded. A question and answer session will follow the formal presentation. [Operator Instructions] I would now turn the conference over to our host from VBL team. Please go ahead.